Elevance Health, Inc.

ELV

Elevance Health, Inc.

ELV

Insider Sentiment (TTM):

Last Purchase:2026-03-05Last Sale:2026-06-12Shares Purchased (TTM):3,000Shares Sold (TTM):5,273

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:183,611,662Shares Outstanding:219,800,000Institutional Ownership Pct.:83.54%

Earnings Market Reaction:

Filing Date:2026-07-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	10,232	9,657	9,491	8,713	8,560	7,500	8,288	7,866	6,497	6,226	6,526	10,919
Available For Sale Securities Debt Securities Curr…	25,719	25,905	25,884	26,283	25,298	25,437	25,201	28,954	28,900	29,530	29,614	27,811
Equity Securities Fv Ni	1,563	1,511	740	1,220	934	715	1,192	1,113	594	511	229	165
Premiums Receivable At Carrying Value	10,991	11,525	10,073	9,535	10,465	10,359	8,011	7,209	8,040	8,931	7,902	7,883
Assets Current
Assets Current	67,184	67,032	63,001	63,778	63,324	61,121	58,942	62,846	62,274	60,948	60,029	61,185
Other Receivables	6,818	6,167	6,307	7,692	7,206	6,576	6,016	6,055	5,881	5,120	5,405	5,293
Other Assets Current	6,278	7,169	5,344	5,213	5,407	5,288	4,700	5,949	6,464	6,388	5,795	5,358
Assets Held For Sale Not Part Of Disposal Group Cu…	-	-	0	0	0	0	490	565	601	-	0	-
Long Term Investments
Available For Sale Securities Debt Securities Nonc…	1,259	1,114	1,121	1,111	1,087	1,060	1,035	893	849	880	876	816
Other Long Term Investments	11,130	11,009	10,839	10,648	10,466	10,167	9,749	9,394	6,810	6,713	6,107	6,118
Property Plant And Equipment Net	4,645	4,657	4,679	4,657	4,641	4,617	4,652	4,505	4,450	4,451	4,359	4,248
Goodwill	28,339	28,340	28,344	28,451	28,368	28,420	28,277	25,967	25,962	25,947	25,317	25,291
Intangible Assets Net Excluding Goodwill	10,983	11,093	11,200	11,327	11,490	11,940	12,094	10,325	10,447	10,710	10,273	10,491
Other Assets Noncurrent	2,898	2,582	2,310	2,777	2,562	2,392	2,140	2,603	2,196	2,245	1,967	2,329
Assets	126,438	125,827	121,494	122,749	121,938	119,717	116,889	116,533	112,988	111,894	108,928	110,478
Liabilities And Stockhold…
Liabilities
Liability For Claims And Claims Adjustment Expense	18,463	18,425	17,084	17,148	17,155	16,812	15,746	15,346	15,204	16,459	16,111	16,176
Other Policyholder Funds	3,463	3,857	3,632	2,447	3,540	3,796	4,204	4,402	4,939	5,298	5,600	5,681
Unearned Premiums	1,640	1,759	1,493	1,831	1,561	1,640	1,508	1,793	1,481	1,474	1,402	4,332
Accounts Payable And Accrued Liabilities Current	6,632	6,209	7,322	6,085	7,278	7,131	6,927	6,255	5,760	5,658	6,910	5,983
Short Term Borrowings	0	724	150	180	360	250	365	360	225	1,575	225	0
Long Term Debt Current	375	350	1,099	749	1,648	1,643	1,649	2,100	2,900	2,900	1,649	799
Other Liabilities Current	13,681	13,985	10,255	12,438	12,292	11,426	10,029	11,614	11,139	10,970	9,894	10,366
Liabilities Of Disposal Group Including Discontinu…	-	-	0	0	0	0	153	163	165	-	0	-
Liabilities Current	44,254	45,309	41,035	40,878	43,834	42,698	40,581	42,033	41,813	44,334	41,791	43,337
Long Term Debt Noncurrent	30,669	30,768	30,797	31,173	28,178	28,110	29,218	24,688	24,561	21,976	23,246	24,045
Liability For Future Policy Benefits	-	-	145	164	163	174	190	248	295	765	778	807
Deferred Income Tax Liabilities Net	2,206	1,786	2,110	2,315	2,008	2,121	2,148	2,092	2,037	2,201	1,970	1,779
Other Liabilities Noncurrent	4,287	3,922	3,381	4,137	3,904	3,994	3,326	3,593	1,985	1,908	1,738	1,971
Liabilities	81,416	81,785	77,468	78,667	78,087	77,097	75,463	72,654	70,691	71,184	69,523	71,939
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	2	2	2	2	2	2	2	2	2	2	2	2
Stockholders Equity
Additional Paid In Capital	8,917	8,845	8,938	8,908	8,931	8,866	8,911	9,105	9,001	8,883	8,868	8,830
Stockholders Equity	45,022	43,902	43,882	43,953	43,722	42,620	41,426	43,879	42,191	40,608	39,306	38,423
Retained Earnings Accumulated Deficit	36,675	35,796	35,393	35,586	35,549	34,546	33,549	35,157	34,575	33,088	31,749	32,103
Accumulated Other Comprehensive Income Loss Net Of…	-711	-741	-451	-543	-760	-911	-1,147	-489	-1,387	-1,365	-1,313	-2,512
Minority Interest	139	140	144	129	129	117	111	104	106	102	99	116
Liabilities And Stockholders Equity	126,438	125,827	121,494	122,749	121,938	119,717	116,889	116,533	112,988	111,894	108,928	110,478
Debt Securities Available For Sale Amortized Cost …	25,962	26,177	25,773	26,200	25,491	25,813	25,879	28,739	29,834	30,427	30,446	30,139
Debt Securities Available For Sale Allowance For C…	55	55	21	13	15	7	6	2	4	4	4	3
Debt Securities Available For Sale Amortized Cost …	1,263	1,121	1,116	1,110	1,099	1,070	1,049	883	867	902	890	874
Debt Securities Available For Sale Allowance For C…	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	900	900	900	900	900	900	900	900	900	900	900	900
Common Stock Shares Issued	217	217	221	222	225	226	227	232	232	233	233	235
Shares Outstanding	217	217	221	222	225	226	227	232	232	233	233	235

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	19.65%	23.62%	27.34%	0.99%	-	-	-	-	-	-	-	-
2025	-3.03%	-7.13%	-17.73%	-2.80%	3.70%	16.52%	-6.84%	3.19%	7.15%	-5.60%	-14.99%	2.33%
2024	2.66%	2.62%	1.28%	2.14%	4.03%	-5.26%	-4.89%	-13.65%	-16.04%	8.25%	13.10%	4.04%
2023	-	-	-	2.34%	-2.80%	-2.54%	-2.36%	2.16%	2.60%	1.05%	-2.02%	6.19%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.52	1.48	1.54	1.56	1.44	1.43	1.45	1.50	1.49	1.37	1.44	1.41
Quick Ratio	1.52	1.48	1.54	1.56	1.44	1.43	1.45	1.50	1.49	1.37	1.44	1.41
Working Capital	22.93B	21.72B	21.97B	22.90B	19.49B	18.42B	18.36B	20.81B	20.46B	16.61B	18.24B	17.85B
Leverage & Debt
Debt to Equity	1.81	1.86	1.76	1.78	1.78	1.81	1.82	1.66	1.67	1.75	1.77	1.87
Interest Coverage TTM	5.08	5.39	5.79	6.16	6.34	7.14	7.67	8.55	9.08	8.71	8.49	8.73
Debt Ratio	0.64	0.65	0.64	0.64	0.64	0.64	0.65	0.62	0.63	0.64	0.64	0.65
Efficiency & Turnover
Asset Turnover TTM	1.62	1.27	1.67	2.23	1.89	1.91	1.57	1.18	1.54	1.90	1.97	1.22
Per Share Metrics
Diluted EPS TTM	22.71	23.77	25.20	24.68	23.70	26.00	25.64	27.55	28.68	26.68	25.24	25.41
Free Cash Flow Per Share TTM	28.98	29.34	14.17	16.87	23.70	16.23	19.65	3.76	36.99	43.25	61.61	68.06
Dividend Per Share TTM	6.94	6.91	6.83	6.83	6.76	6.69	6.51	6.39	6.25	6.12	5.91	5.75
Margin Metrics
Gross Profit Margin TTM	89.12%	86.16%	89.36%	91.88%	90.37%	90.56%	88.84%	86.18%	89.42%	91.58%	91.73%	87.66%
Operating Profit Margin TTM	2.92%	3.97%	3.37%	2.66%	3.19%	3.51%	4.47%	6.18%	5.01%	3.84%	3.69%	5.95%
Net Profit Margin TTM	2.46%	3.35%	2.84%	2.07%	2.41%	2.67%	3.37%	4.78%	3.91%	2.98%	2.87%	4.61%
Growth Metrics
Net Revenue Growth (1Y)	-9.47%	-29.33%	12.49%	98.49%	29.51%	5.69%	-15.31%	3.00%	34.32%	70.98%	33.47%	-14.86%
Net Income Growth (1Y)	-7.51%	-11.34%	-5.19%	-14.01%	-20.07%	-5.44%	-0.33%	6.87%	5.88%	2.36%	1.65%	-2.20%
EPS Growth (1Y)	-4.02%	-8.68%	-1.93%	-10.70%	-17.59%	-2.81%	1.47%	8.44%	7.89%	4.47%	3.41%	-0.41%
Valuation Metrics
P/E TTM	16.96	12.23	13.73	12.87	16.03	16.25	13.90	18.16	18.12	18.56	17.79	16.29
P/B TTM	1.86	1.46	1.77	1.61	1.96	2.25	2.00	2.66	2.87	2.85	2.71	2.55
P/S TTM	0.42	0.41	0.39	0.27	0.39	0.43	0.47	0.87	0.71	0.55	0.51	0.75
Market Cap	83.92B	64.09B	77.73B	71.05B	85.79B	96.03B	83.00B	116.62B	121.32B	115.99B	106.59B	97.87B
Enterprise Value	104.73B	86.27B	100.28B	94.44B	107.42B	118.53B	105.94B	135.90B	142.50B	136.22B	125.18B	111.79B
Calculated Values
Free Cash Flow TTM	6.29B	6.45B	3.17B	3.77B	5.34B	3.67B	4.55B	871.00M	8.59B	10.06B	14.53B	16.01B
Net Debt	20.81B	22.19B	22.56B	23.39B	21.63B	22.50B	22.94B	19.28B	21.19B	20.23B	18.59B	13.93B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-12Sale

Owner: Penczek, Ronald W

Title: CAO & Controller

Shares: 369

Price/Share: $403.16

Value: $148,766.04

Shares Owned: 3,740

Relationship: Officer

Ownership: Direct

2026-06-11Sale

Owner: Dixon, Robert L Jr

Title: -

Shares: 151

Price/Share: $401.77

Value: $60,667.27

Shares Owned: 10,734

Relationship: Director

Ownership: Direct

2026-05-19Sale

Owner: Penczek, Ronald W

Title: CAO & Controller

Shares: 1,531

Price/Share: $403.13

Value: $617,192.03

Shares Owned: 4,109

Relationship: Officer

Ownership: Direct

2026-03-12Sale

Owner: Schulman, Amy W

Title: -

Shares: 26

Price/Share: $287.50

Value: $7,475.00

Shares Owned: 218

Relationship: Director

Ownership: Direct

2026-03-06Sale

Owner: Kendrick, Charles Morgan …

Title: EVP & President, Commercial

Shares: 3,196

Price/Share: $284.92

Value: $910,604.32

Shares Owned: 11,791

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-12	Penczek, Ronald W	Officer	CAO & Controller	Direct	Sale	369	403.16	$148,766.04	3,740	4
2026-06-11	Dixon, Robert L Jr	Director	-	Direct	Sale	151	401.77	$60,667.27	10,734	4
2026-05-19	Penczek, Ronald W	Officer	CAO & Controller	Direct	Sale	1,531	403.13	$617,192.03	4,109	4
2026-03-12	Schulman, Amy W	Director	-	Direct	Sale	26	287.50	$7,475.00	218	4
2026-03-06	Kendrick, Charles Morgan …	Officer	EVP & President, Commercial	Direct	Sale	3,196	284.92	$910,604.32	11,791	4
2026-03-05	Collis, Steven H	Director	-	Direct	Purchase	3,000	289.84	$869,520.00	3,639	4
2025-08-19	Devore, Susan D.	Director	-	Direct	Purchase	1,200	312.15	$374,580.00	3,502	4
2025-07-18	Boudreaux, Gail	Director,Officer	President and CEO	Direct	Purchase	8,500	287.05	$2,439,925.00	151,020	4
2025-04-24	Kaye, Mark	Officer	EVP & CFO	Direct	Sale	4,588	424.82	$1,949,074.16	18,977	4
2025-03-10	Penczek, Ronald W	Officer	CAO & Controller	Direct	Sale	443	415.13	$183,902.59	1,847	4
2025-03-05	Kendrick, Charles Morgan …	Officer	EVP & President, Commercial	Direct	Sale	3,504	396.30	$1,388,635.20	10,116	4
2024-10-18	Kendrick, Charles Morgan …	Officer	EVP & President, Commercial	Direct	Sale	7,417	432.14	$3,205,182.38	8,423	4
2024-08-05	Peru, Ramiro G	Director	-	Direct	Sale	753	531.52	$400,234.56	8,744	4
2024-07-22	Boudreaux, Gail	Director,Officer	President and CEO	Direct	Sale	34,000	501.74	$17,059,160.00	126,709	4
2024-07-19	Dixon, Robert L Jr	Director	-	Direct	Sale	305	506.76	$154,561.80	9,721	4
2024-04-24	Norwood, Felicia F	Officer	EVP & President,Gov Health Ben	Direct	Sale	6,199	532.41	$3,300,409.59	27,304	4
2024-03-08	Kendrick, Charles Morgan …	Officer	EVP & President, Commercial	Direct	Sale	2,432	500.46	$1,217,118.72	15,840	4
2024-03-06	Penczek, Ronald W	Officer	CAO & Controller	Direct	Sale	916	504.58	$462,195.28	1,764	4
2024-03-04	Haytaian, Peter D	Officer	EVP & Pres Carelon & CarelonRx	Direct	Sale	21,095	500.18	$10,551,297.10	18,887	4
2024-02-07	Peru, Ramiro G	Director	-	Direct	Sale	753	500.00	$376,500.00	9,109	4
2023-12-14	Todt, Blair Williams	Officer	EVP, CLO & CAO	Direct	Sale	5,492	484.02	$2,658,237.84	12,512	4
2023-11-30	Penczek, Ronald W	Officer	CAO & Controller	Direct	Sale	1,055	475.17	$501,304.35	1,787	4
2023-10-24	Penczek, Ronald W	Officer	CAO & Controller	Direct	Sale	64	454.35	$29,078.40	2,842	4
2023-07-21	Dixon, Robert L Jr	Director	-	Direct	Sale	310	476.71	$147,780.10	9,638	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

83.54%

Inst. Shares: 183,611,662

Shares Outstanding: 219,800,000

2025-12-31

83.95%

Inst. Shares: 188,058,425

Shares Outstanding: 224,000,000

2025-09-30

82.43%

Inst. Shares: 184,061,018

Shares Outstanding: 223,300,000

2025-06-30

84.06%

Inst. Shares: 189,296,329

Shares Outstanding: 225,200,000

2025-03-31

82.27%

Inst. Shares: 186,259,928

Shares Outstanding: 226,400,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	183,611,662	219,800,000	83.54%
2025-12-31	188,058,425	224,000,000	83.95%
2025-09-30	184,061,018	223,300,000	82.43%
2025-06-30	189,296,329	225,200,000	84.06%
2025-03-31	186,259,928	226,400,000	82.27%
2024-12-31	189,732,550	231,700,000	81.89%
2024-09-30	184,513,392	231,900,000	79.57%
2024-06-30	187,644,135	232,200,000	80.81%
2024-03-31	183,490,707	232,700,000	78.85%
2023-12-31	187,084,305	235,900,000	79.31%
2023-09-30	184,447,690	235,300,000	78.39%
2023-06-30	184,805,490	236,600,000	78.11%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Elevance Health, Inc. (ELV) — SEC Financial Statements & Analysis

Elevance Health, Inc. (ELV) is a hospital & medical service plans company, incorporated in IN. Elevance Health, Inc. trades on NYSE as: ELV. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Elevance Health, Inc. reported a -9.47% year-over-year revenue growth, a Gross Profit Margin of 89.12% (TTM), a Debt-to-Equity ratio of 1.81x, a Price-to-Sales (P/S) ratio of 0.42x (TTM), a Price-to-Book (P/B) ratio of 1.86x (TTM), at a market cap of $83.92B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -9.47%
Gross Profit Margin TTM: 89.12%
Debt To Equity: 1.81x
P/S TTM: 0.42x
P/B TTM: 1.86x
Market Cap: $83.92B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Elevance Health, Inc. in?

Elevance Health, Inc. (ELV) operates in the Hospital & Medical Service Plans industry.

What is ELV's market cap?

Elevance Health, Inc. (ELV) has a market capitalization of $83.92B as of 2026-06-30.

What is ELV's P/E ratio?

Elevance Health, Inc. (ELV)'s trailing twelve month P/E ratio is 16.96x as of 2026-06-30.

What exchange does ELV trade on?

Elevance Health, Inc. (ELV) trades on the NYSE.

Where is Elevance Health, Inc. incorporated?

Elevance Health, Inc. is incorporated in IN.